Concepts (214)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 14 | 2025 | 1582 | 1.060 |
Why?
|
| Environmental Monitoring | 5 | 2013 | 145 | 1.020 |
Why?
|
| Groundwater | 2 | 2015 | 4 | 0.900 |
Why?
|
| Water Movements | 6 | 2013 | 7 | 0.850 |
Why?
|
| Craniocerebral Trauma | 3 | 2021 | 56 | 0.780 |
Why?
|
| Models, Theoretical | 5 | 2015 | 271 | 0.730 |
Why?
|
| Contrast Media | 7 | 2023 | 421 | 0.720 |
Why?
|
| Water Pollutants, Chemical | 3 | 2010 | 40 | 0.650 |
Why?
|
| Neuroimaging | 3 | 2021 | 153 | 0.600 |
Why?
|
| Societies, Medical | 10 | 2024 | 362 | 0.490 |
Why?
|
| Head | 1 | 2016 | 55 | 0.480 |
Why?
|
| Evidence-Based Medicine | 8 | 2024 | 458 | 0.420 |
Why?
|
| Water Supply | 3 | 2010 | 13 | 0.410 |
Why?
|
| Brain | 4 | 2025 | 1546 | 0.370 |
Why?
|
| Wounds, Penetrating | 2 | 2024 | 26 | 0.370 |
Why?
|
| Brain Injuries | 2 | 2022 | 140 | 0.360 |
Why?
|
| Soil Pollutants | 3 | 2010 | 26 | 0.350 |
Why?
|
| Cerebrovascular Circulation | 4 | 2025 | 178 | 0.350 |
Why?
|
| Industrial Waste | 3 | 2010 | 6 | 0.350 |
Why?
|
| Water Pollutants | 3 | 2008 | 4 | 0.350 |
Why?
|
| Computed Tomography Angiography | 4 | 2020 | 123 | 0.330 |
Why?
|
| Multiple Trauma | 2 | 2007 | 27 | 0.280 |
Why?
|
| Head Injuries, Closed | 1 | 2007 | 15 | 0.280 |
Why?
|
| Dermoid Cyst | 1 | 2007 | 3 | 0.280 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2007 | 152 | 0.260 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2006 | 13 | 0.260 |
Why?
|
| Intracranial Pressure | 2 | 2025 | 19 | 0.250 |
Why?
|
| Abdominal Pain | 2 | 2005 | 101 | 0.250 |
Why?
|
| Appendicitis | 2 | 2005 | 78 | 0.240 |
Why?
|
| Brain Neoplasms | 2 | 2016 | 308 | 0.240 |
Why?
|
| Intracranial Hypertension | 1 | 2025 | 10 | 0.240 |
Why?
|
| Shock, Hemorrhagic | 1 | 2025 | 19 | 0.240 |
Why?
|
| Diagnostic Imaging | 4 | 2024 | 261 | 0.230 |
Why?
|
| Orbital Fractures | 1 | 2024 | 8 | 0.230 |
Why?
|
| Seawater | 2 | 2015 | 11 | 0.220 |
Why?
|
| Emergency Service, Hospital | 4 | 2016 | 1064 | 0.220 |
Why?
|
| Whole-Body Counting | 1 | 2003 | 4 | 0.220 |
Why?
|
| Fresh Water | 3 | 2015 | 12 | 0.220 |
Why?
|
| Trauma Severity Indices | 1 | 2003 | 34 | 0.220 |
Why?
|
| Pulmonary Embolism | 1 | 2006 | 169 | 0.220 |
Why?
|
| Diagnosis, Differential | 6 | 2019 | 959 | 0.210 |
Why?
|
| Amiodarone | 1 | 2003 | 21 | 0.210 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2020 | 107 | 0.200 |
Why?
|
| Carotid Artery Diseases | 1 | 2003 | 66 | 0.200 |
Why?
|
| Radiation Dosage | 1 | 2003 | 133 | 0.200 |
Why?
|
| Calcinosis | 1 | 2003 | 83 | 0.200 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2024 | 93 | 0.200 |
Why?
|
| Humans | 28 | 2024 | 62457 | 0.190 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2003 | 99 | 0.190 |
Why?
|
| Perfusion Imaging | 1 | 2021 | 19 | 0.190 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2003 | 90 | 0.190 |
Why?
|
| Sensitivity and Specificity | 7 | 2018 | 1138 | 0.180 |
Why?
|
| Nervous System Diseases | 1 | 2003 | 106 | 0.180 |
Why?
|
| Triage | 1 | 2002 | 115 | 0.180 |
Why?
|
| Hemorrhage | 2 | 2021 | 266 | 0.180 |
Why?
|
| Hypotension | 1 | 2021 | 50 | 0.180 |
Why?
|
| Rivers | 2 | 2015 | 21 | 0.180 |
Why?
|
| Glasgow Coma Scale | 3 | 2024 | 46 | 0.180 |
Why?
|
| Resuscitation | 1 | 2021 | 66 | 0.180 |
Why?
|
| Male | 17 | 2025 | 29368 | 0.180 |
Why?
|
| Cardiac Catheterization | 1 | 2003 | 278 | 0.170 |
Why?
|
| Trauma Centers | 2 | 2024 | 118 | 0.170 |
Why?
|
| Upper Extremity Deep Vein Thrombosis | 1 | 2020 | 5 | 0.170 |
Why?
|
| Adolescent | 8 | 2024 | 6147 | 0.170 |
Why?
|
| Predictive Value of Tests | 5 | 2018 | 1076 | 0.170 |
Why?
|
| Child, Preschool | 5 | 2018 | 1928 | 0.160 |
Why?
|
| United States | 10 | 2024 | 7696 | 0.160 |
Why?
|
| Iodine | 1 | 2019 | 19 | 0.160 |
Why?
|
| Germany | 3 | 2015 | 53 | 0.160 |
Why?
|
| Child | 8 | 2021 | 4429 | 0.160 |
Why?
|
| Patient Outcome Assessment | 1 | 2019 | 53 | 0.160 |
Why?
|
| Radiographic Image Enhancement | 1 | 2019 | 98 | 0.150 |
Why?
|
| Mesenteric Ischemia | 1 | 2018 | 6 | 0.150 |
Why?
|
| Vasculitis | 1 | 2019 | 50 | 0.150 |
Why?
|
| Retrospective Studies | 8 | 2024 | 6486 | 0.150 |
Why?
|
| Radiography, Thoracic | 2 | 2018 | 115 | 0.150 |
Why?
|
| Uncertainty | 2 | 2010 | 34 | 0.150 |
Why?
|
| Swine | 3 | 2025 | 368 | 0.150 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 2 | 2010 | 18 | 0.150 |
Why?
|
| Thermography | 1 | 2018 | 7 | 0.150 |
Why?
|
| Middle Aged | 12 | 2024 | 17294 | 0.140 |
Why?
|
| Neck Injuries | 1 | 2017 | 19 | 0.140 |
Why?
|
| Venous Thrombosis | 1 | 2018 | 113 | 0.140 |
Why?
|
| Hospitals, Teaching | 1 | 2018 | 104 | 0.140 |
Why?
|
| Hypothermia | 1 | 2017 | 17 | 0.140 |
Why?
|
| Leg | 1 | 2017 | 87 | 0.130 |
Why?
|
| Lower Extremity | 1 | 2018 | 164 | 0.130 |
Why?
|
| Peripheral Arterial Disease | 1 | 2019 | 172 | 0.130 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2017 | 133 | 0.130 |
Why?
|
| Pulmonary Veins | 1 | 2016 | 38 | 0.130 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2016 | 8 | 0.130 |
Why?
|
| Infarction | 1 | 2016 | 20 | 0.130 |
Why?
|
| Unnecessary Procedures | 1 | 2016 | 44 | 0.130 |
Why?
|
| Status Epilepticus | 1 | 2016 | 23 | 0.120 |
Why?
|
| Arteriovenous Fistula | 1 | 2016 | 41 | 0.120 |
Why?
|
| Anisotropy | 2 | 2007 | 60 | 0.120 |
Why?
|
| Pulmonary Artery | 1 | 2016 | 93 | 0.120 |
Why?
|
| Hydrology | 1 | 2015 | 1 | 0.120 |
Why?
|
| Estuaries | 1 | 2015 | 1 | 0.120 |
Why?
|
| Salinity | 1 | 2015 | 5 | 0.120 |
Why?
|
| Radiology | 2 | 2017 | 247 | 0.120 |
Why?
|
| Female | 13 | 2024 | 32378 | 0.120 |
Why?
|
| Aged | 9 | 2024 | 14203 | 0.120 |
Why?
|
| Ischemia | 1 | 2017 | 203 | 0.120 |
Why?
|
| Climate Change | 1 | 2015 | 24 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 2 | 2016 | 725 | 0.120 |
Why?
|
| Pneumonia | 1 | 2018 | 286 | 0.120 |
Why?
|
| Hospital Mortality | 1 | 2019 | 864 | 0.110 |
Why?
|
| Kinetics | 2 | 2008 | 763 | 0.110 |
Why?
|
| Guideline Adherence | 1 | 2016 | 306 | 0.110 |
Why?
|
| Multivariate Analysis | 2 | 2008 | 928 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2016 | 667 | 0.100 |
Why?
|
| Injections, Intra-Arterial | 2 | 2023 | 21 | 0.100 |
Why?
|
| Computer Simulation | 1 | 2015 | 476 | 0.100 |
Why?
|
| Adult | 8 | 2024 | 16567 | 0.100 |
Why?
|
| Ontario | 1 | 2010 | 44 | 0.090 |
Why?
|
| Massachusetts | 3 | 2018 | 2061 | 0.090 |
Why?
|
| Models, Chemical | 1 | 2010 | 139 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 5390 | 0.080 |
Why?
|
| Stochastic Processes | 1 | 2008 | 26 | 0.070 |
Why?
|
| Monte Carlo Method | 1 | 2008 | 90 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2008 | 255 | 0.070 |
Why?
|
| Rupture, Spontaneous | 1 | 2007 | 21 | 0.070 |
Why?
|
| Pneumocephalus | 1 | 2007 | 8 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 212 | 0.070 |
Why?
|
| Equipment Design | 1 | 2008 | 348 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2008 | 307 | 0.070 |
Why?
|
| Prevalence | 2 | 2024 | 1343 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2007 | 2141 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 2165 | 0.060 |
Why?
|
| Accidents, Traffic | 1 | 2007 | 151 | 0.060 |
Why?
|
| Benzene | 1 | 2005 | 7 | 0.060 |
Why?
|
| Appendix | 1 | 2005 | 15 | 0.060 |
Why?
|
| Cerebral Blood Volume | 1 | 2025 | 1 | 0.060 |
Why?
|
| Gallbladder Diseases | 1 | 2005 | 25 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 453 | 0.060 |
Why?
|
| Torso | 1 | 2024 | 19 | 0.060 |
Why?
|
| Animals | 4 | 2025 | 20525 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 1636 | 0.060 |
Why?
|
| Thoracic Injuries | 1 | 2024 | 46 | 0.060 |
Why?
|
| Phenanthrenes | 1 | 2003 | 7 | 0.050 |
Why?
|
| Time Factors | 2 | 2008 | 3737 | 0.050 |
Why?
|
| Length of Stay | 1 | 2007 | 797 | 0.050 |
Why?
|
| Diffusion | 1 | 2003 | 83 | 0.050 |
Why?
|
| Adsorption | 1 | 2003 | 83 | 0.050 |
Why?
|
| Thoracic Vertebrae | 1 | 2003 | 33 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 30 | 0.050 |
Why?
|
| Spinal Fractures | 1 | 2003 | 37 | 0.050 |
Why?
|
| Hydrocarbons | 1 | 2003 | 9 | 0.050 |
Why?
|
| Hypercholesterolemia | 1 | 2003 | 70 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2003 | 106 | 0.050 |
Why?
|
| Statistics as Topic | 1 | 2003 | 148 | 0.050 |
Why?
|
| Perfusion | 1 | 2022 | 73 | 0.050 |
Why?
|
| Models, Animal | 1 | 2023 | 235 | 0.050 |
Why?
|
| Lumbar Vertebrae | 1 | 2003 | 142 | 0.050 |
Why?
|
| Sus scrofa | 1 | 2021 | 28 | 0.050 |
Why?
|
| Particle Size | 1 | 2003 | 407 | 0.050 |
Why?
|
| Heart Diseases | 1 | 2003 | 215 | 0.040 |
Why?
|
| Acute Disease | 2 | 2017 | 670 | 0.040 |
Why?
|
| Sex Factors | 1 | 2003 | 968 | 0.040 |
Why?
|
| Logistic Models | 1 | 2003 | 1272 | 0.040 |
Why?
|
| Environmental Restoration and Remediation | 2 | 2010 | 5 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2003 | 747 | 0.040 |
Why?
|
| Upper Extremity | 1 | 2020 | 53 | 0.040 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2019 | 4 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2005 | 532 | 0.040 |
Why?
|
| Contusions | 1 | 2019 | 11 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2022 | 513 | 0.040 |
Why?
|
| Age Factors | 1 | 2003 | 1552 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2005 | 2033 | 0.040 |
Why?
|
| Smoking | 1 | 2003 | 864 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 37 | 0.040 |
Why?
|
| Hypertension | 1 | 2003 | 590 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 1537 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2003 | 2439 | 0.030 |
Why?
|
| Urban Population | 1 | 2018 | 189 | 0.030 |
Why?
|
| Angiography | 1 | 2017 | 151 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2018 | 608 | 0.030 |
Why?
|
| Unconsciousness | 1 | 2016 | 3 | 0.030 |
Why?
|
| Utilization Review | 1 | 2016 | 32 | 0.030 |
Why?
|
| Piracetam | 1 | 2016 | 8 | 0.030 |
Why?
|
| Acyclovir | 1 | 2016 | 19 | 0.030 |
Why?
|
| Phenytoin | 1 | 2016 | 18 | 0.030 |
Why?
|
| Ceftriaxone | 1 | 2016 | 19 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2017 | 184 | 0.030 |
Why?
|
| Propofol | 1 | 2016 | 24 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 2016 | 46 | 0.030 |
Why?
|
| Fever | 1 | 2016 | 66 | 0.030 |
Why?
|
| Vancomycin | 1 | 2016 | 38 | 0.030 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 66 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2018 | 561 | 0.030 |
Why?
|
| Boston | 1 | 2016 | 251 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2016 | 146 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2016 | 205 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2016 | 173 | 0.030 |
Why?
|
| Pain | 1 | 2017 | 405 | 0.030 |
Why?
|
| Risk Factors | 1 | 2024 | 5288 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2016 | 321 | 0.030 |
Why?
|
| Infant | 1 | 2018 | 1591 | 0.030 |
Why?
|
| Biodegradation, Environmental | 1 | 2010 | 11 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2021 | 5554 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 783 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 4610 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2005 | 40 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2005 | 78 | 0.010 |
Why?
|
| Appendectomy | 1 | 2005 | 52 | 0.010 |
Why?
|
| ROC Curve | 1 | 2005 | 277 | 0.010 |
Why?
|
| Viscera | 1 | 2003 | 10 | 0.010 |
Why?
|
| Radiography, Abdominal | 1 | 2003 | 26 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2005 | 470 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2005 | 851 | 0.010 |
Why?
|
| Incidence | 1 | 2005 | 1359 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2005 | 2530 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2003 | 3246 | 0.010 |
Why?
|